Microbicides Research, Development, and Introduction

Post Date

July 30th 2012

Application Due Date

November 30th -0001

TBD

Funding Opportunity Number

APS-OAA-12-000007

CFDA Number(s)

98.001

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Other

Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the Agencyуs microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. This APS is intended to support the creative research and other innovative activities that are now essential to advance potential microbicides toward regulatory approval and then to successfully introduce them into delivery programs. Attaining these objectives will fill a critical gap in the options women and girls currently have to protect themselves from HIV infection.

Eligibility Categories

Other

Elibility requirements included in attached document.

Funding

• Award Range:

  $100000 - $2250000

Grant Description

Clinical trials of vaginal microbicide have been tested recently in South Africa to determine efficacy of reduction of HIV infection. Microbicide research, development, and introduction activities which could potentially be supported through this APS mechanism are expected to contribute substantially to the Principles of the Global Health Initiative (GHI), particularly in promoting research and innovation; implementing a woman- and girl-centered approach; strengthening and leveraging inputs from multilateral organizations, global health partnerships, and the private sector; and encouraging country ownership and leadership. Potential activities could also contribute significantly to strengthening the health system building blocks related to commodities and procurement, service delivery, and leadership and governance. It is expected that gender analyses and other gender considerations will continue to inform the design and implementation of activities implemented as part of the Agencyуs microbicide program. All awards will also be subject to USAID environmental requirements, including completion of an initial environmental examination. See attached APS for full Funding Opportunity description.

Contact Information

• Agency

  Agency for International Development

• Office:

  None

• Agency Contact:

  Kathleen Bumpass
  Contracts Specialist
  Phone 202-567-5008

• Agency Mailing Address:

  Agreement Specialist

• Agency Email Address:

  kbumpass@usaid.gov